177 related articles for article (PubMed ID: 2465159)
1. Positive inotropic effects in isolated ventricular myocardium from non-failing and terminally failing human hearts.
Näbauer M; Böhm M; Brown L; Diet F; Eichhorn M; Kemkes B; Pieske B; Erdmann E
Eur J Clin Invest; 1988 Dec; 18(6):600-6. PubMed ID: 2465159
[TBL] [Abstract][Full Text] [Related]
2. Reduction of beta-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium.
Böhm M; Beuckelmann D; Brown L; Feiler G; Lorenz B; Näbauer M; Kemkes B; Erdmann E
Eur Heart J; 1988 Aug; 9(8):844-52. PubMed ID: 2460351
[TBL] [Abstract][Full Text] [Related]
3. Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations.
von der Leyen H; Mende U; Meyer W; Neumann J; Nose M; Schmitz W; Scholz H; Starbatty J; Stein B; Wenzlaff H
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):90-100. PubMed ID: 1723153
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a sustained effectiveness of sodium-channel activators in failing human myocardium.
Schwinger RH; Böhm M; Mittmann C; La Rosée K; Erdmann E
J Mol Cell Cardiol; 1991 Apr; 23(4):461-71. PubMed ID: 1658340
[TBL] [Abstract][Full Text] [Related]
5. The effect of positive inotropes on the failing human myocardium.
Erdmann E
Cardiology; 1997; 88 Suppl 2():7-11. PubMed ID: 9142430
[TBL] [Abstract][Full Text] [Related]
6. Influence of forskolin on the force-frequency behavior in nonfailing and end-stage failing human myocardium.
Pieske B; Trost S; Schütt K; Minami K; Just H; Hasenfuss G
Basic Res Cardiol; 1998; 93 Suppl 1():66-75. PubMed ID: 9833133
[TBL] [Abstract][Full Text] [Related]
7. Reduced alpha 1- and beta 2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failure.
Steinfath M; Danielsen W; von der Leyen H; Mende U; Meyer W; Neumann J; Nose M; Reich T; Schmitz W; Scholz H
Br J Pharmacol; 1992 Feb; 105(2):463-9. PubMed ID: 1348446
[TBL] [Abstract][Full Text] [Related]
8. Effect of inotropic interventions on the force-frequency relation in the human heart.
Bavendiek U; Brixius K; Münch G; Zobel C; Müller-Ehmsen J; Schwinger RH
Basic Res Cardiol; 1998; 93 Suppl 1():76-85. PubMed ID: 9833134
[TBL] [Abstract][Full Text] [Related]
9. Effects of the benzimidazole derivatives pimobendan and 2-(4-hydroxy-phenyl)-5-(5-methyl-3-oxo-4,5-dihydro-2H-6- pyridazinyl) benzimidazole . HCl on phosphodiesterase activity and force of contraction in guinea-pig hearts.
Berger C; Meyer W; Scholz H; Starbatty J
Arzneimittelforschung; 1985; 35(11):1668-73. PubMed ID: 2418846
[TBL] [Abstract][Full Text] [Related]
10. Incomplete reversal of beta-adrenoceptor desensitization in human and guinea-pig cardiomyocytes by cyclic nucleotide phosphodiesterase inhibitors.
Wynne DG; Poole-Wilson PA; Harding SE
Br J Pharmacol; 1993 Aug; 109(4):1071-8. PubMed ID: 7691363
[TBL] [Abstract][Full Text] [Related]
11. Adenylyl cyclase-mediated effects contribute to increased Isoprenaline-induced cardiac contractility in TRPM4-deficient mice.
Uhl S; Mathar I; Vennekens R; Freichel M
J Mol Cell Cardiol; 2014 Sep; 74():307-17. PubMed ID: 24972051
[TBL] [Abstract][Full Text] [Related]
12. Subsensitivity of the failing human heart to isoprenaline and milrinone is related to beta-adrenoceptor downregulation.
Böhm M; Diet F; Feiler G; Kemkes B; Kreuzer E; Weinhold C; Erdmann E
J Cardiovasc Pharmacol; 1988 Dec; 12(6):726-32. PubMed ID: 2467092
[TBL] [Abstract][Full Text] [Related]
13. Noradrenaline-induced desensitization in cultured heart cells as a model for the defects of the adenylate cyclase system in severe heart failure.
Reithmann C; Werdan K
Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):138-44. PubMed ID: 2471084
[TBL] [Abstract][Full Text] [Related]
14. EMD 53998 acts as Ca(2+)-sensitizer and phosphodiesterase III-inhibitor in human myocardium.
Uhlmann R; Schwinger RH; Lues I; Erdmann E
Basic Res Cardiol; 1995; 90(5):365-71. PubMed ID: 8585857
[TBL] [Abstract][Full Text] [Related]
15. Positive inotropic effects of the calcium channel activator Bay K 8644 on guinea-pig and human isolated myocardium.
Näbauer M; Brown L; Erdmann E
Naunyn Schmiedebergs Arch Pharmacol; 1988 Jan; 337(1):85-92. PubMed ID: 2452989
[TBL] [Abstract][Full Text] [Related]
16. Increase in force of contraction by activation of the Na+/Ca(2+)-exchanger in human myocardium.
Müller-Ehmsen J; Frank K; Brixius K; Schwinger RH
Br J Clin Pharmacol; 1997 Apr; 43(4):399-405. PubMed ID: 9146852
[TBL] [Abstract][Full Text] [Related]
17. Concentration-response curves of positive inotropic agents before and after ouabain pretreatment.
Brown L; Erdmann E
Cardiovasc Res; 1985 May; 19(5):288-98. PubMed ID: 3995524
[TBL] [Abstract][Full Text] [Related]
18. Inotropic and lusitropic dysfunction in myocardium from patients with dilated cardiomyopathy.
Schwinger RH; Böhm M; Erdmann E
Am Heart J; 1992 Jan; 123(1):116-28. PubMed ID: 1309621
[TBL] [Abstract][Full Text] [Related]
19. Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure.
Feldman MD; Copelas L; Gwathmey JK; Phillips P; Warren SE; Schoen FJ; Grossman W; Morgan JP
Circulation; 1987 Feb; 75(2):331-9. PubMed ID: 2433073
[TBL] [Abstract][Full Text] [Related]
20. Effect of inotropic stimulation on the negative force-frequency relationship in the failing human heart.
Schwinger RH; Böhm M; Müller-Ehmsen J; Uhlmann R; Schmidt U; Stäblein A; Uberfuhr P; Kreuzer E; Reichart B; Eissner HJ
Circulation; 1993 Nov; 88(5 Pt 1):2267-76. PubMed ID: 8222121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]